Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum LeMaitre Vascular Inc LMAT

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular... see more

Bullboard (NDAQ:LMAT)

View:
Post by aett258on Oct 27, 2016 8:26am

Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Inc (+61%)

LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) LMAT | 16 hours ago BURLINGTON, Mass., Oct. 26, 2016 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a ...more  
Post by aett258on Sep 06, 2016 2:25pm

Why the +10% jump today?

I know it is a great company but why recent surge? Anyone.
Post by aett258on Jul 29, 2016 3:27pm

What transpired in 2Q?

LeMaitre Vascular Inc (NASDAQ:LMAT) released 2Q2016 earnings that the market quickly well in love with and the shares shot up. But digesting the earnings data can help you make a great investment ...more  
Post by aett258on Jul 29, 2016 7:40am

Record Q2 2016 Results

Q2 2016 Results Record sales of $22.4mm, +13% vs. Q2 2015 Gross margin of 68.6% vs. 66.0% Record op. income of $3.8mm vs. $2.8mm, +35% Op. margin of 17% vs. 14 ...more  
Post by aett258on Jul 28, 2016 1:44pm

Hello, any body there?

What about those results. Up +15% today. Cheers
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities